Chlorine in PDB 6a4i: Crystal Structure of Human Tdo Inhibitor Complex
Enzymatic activity of Crystal Structure of Human Tdo Inhibitor Complex
All present enzymatic activity of Crystal Structure of Human Tdo Inhibitor Complex:
1.13.11.11;
Protein crystallography data
The structure of Crystal Structure of Human Tdo Inhibitor Complex, PDB code: 6a4i
was solved by
G.Fu,
J.Wang,
G.Luo,
G.Wu,
K.Qian,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
106.17 /
2.65
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
156.308,
144.106,
89.002,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.5 /
26.9
|
Other elements in 6a4i:
The structure of Crystal Structure of Human Tdo Inhibitor Complex also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Tdo Inhibitor Complex
(pdb code 6a4i). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of Human Tdo Inhibitor Complex, PDB code: 6a4i:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6a4i
Go back to
Chlorine Binding Sites List in 6a4i
Chlorine binding site 1 out
of 4 in the Crystal Structure of Human Tdo Inhibitor Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human Tdo Inhibitor Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl402
b:70.7
occ:1.00
|
CLA
|
A:9R9402
|
0.0
|
70.7
|
1.0
|
CAB
|
A:9R9402
|
1.6
|
58.7
|
1.0
|
CAC
|
A:9R9402
|
2.6
|
52.3
|
1.0
|
CAA
|
A:9R9402
|
2.7
|
50.1
|
1.0
|
CD2
|
B:TYR45
|
3.4
|
70.5
|
1.0
|
CB
|
A:ALA150
|
3.7
|
76.1
|
1.0
|
CE2
|
B:TYR45
|
3.8
|
73.1
|
1.0
|
CAD
|
A:9R9402
|
3.8
|
53.0
|
1.0
|
CAF
|
A:9R9402
|
3.9
|
54.4
|
1.0
|
CE2
|
A:PHE72
|
4.0
|
60.5
|
1.0
|
CD2
|
B:TYR42
|
4.2
|
59.3
|
1.0
|
CG
|
B:TYR45
|
4.3
|
68.4
|
1.0
|
CAE
|
A:9R9402
|
4.3
|
57.9
|
1.0
|
CA
|
B:TYR42
|
4.5
|
62.2
|
1.0
|
CG
|
A:LEU147
|
4.6
|
73.6
|
1.0
|
CB
|
B:TYR45
|
4.6
|
71.5
|
1.0
|
CZ
|
A:PHE72
|
4.9
|
61.8
|
1.0
|
CB
|
B:TYR42
|
4.9
|
61.4
|
1.0
|
CD1
|
B:LEU46
|
4.9
|
54.8
|
1.0
|
CA
|
A:ALA150
|
4.9
|
85.1
|
1.0
|
C
|
A:ALA150
|
4.9
|
87.3
|
1.0
|
CE2
|
B:TYR42
|
4.9
|
58.7
|
1.0
|
CG
|
B:TYR42
|
4.9
|
62.0
|
1.0
|
CD2
|
B:LEU46
|
4.9
|
52.5
|
1.0
|
CZ
|
B:TYR45
|
4.9
|
74.9
|
1.0
|
CD2
|
A:PHE72
|
5.0
|
59.5
|
1.0
|
CG
|
B:LEU46
|
5.0
|
58.7
|
1.0
|
N
|
A:SER151
|
5.0
|
83.9
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6a4i
Go back to
Chlorine Binding Sites List in 6a4i
Chlorine binding site 2 out
of 4 in the Crystal Structure of Human Tdo Inhibitor Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human Tdo Inhibitor Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl402
b:70.8
occ:1.00
|
CLA
|
B:9R9402
|
0.0
|
70.8
|
1.0
|
CAB
|
B:9R9402
|
1.6
|
70.7
|
1.0
|
CAC
|
B:9R9402
|
2.6
|
63.4
|
1.0
|
CAA
|
B:9R9402
|
2.6
|
67.6
|
1.0
|
CD2
|
A:TYR45
|
3.2
|
79.9
|
1.0
|
CE2
|
A:TYR45
|
3.5
|
74.6
|
1.0
|
CB
|
B:ALA150
|
3.8
|
90.2
|
1.0
|
CAD
|
B:9R9402
|
3.8
|
64.7
|
1.0
|
CAF
|
B:9R9402
|
3.9
|
66.7
|
1.0
|
CD2
|
A:TYR42
|
4.0
|
73.8
|
1.0
|
CE2
|
B:PHE72
|
4.0
|
66.5
|
1.0
|
CG
|
A:TYR45
|
4.1
|
84.3
|
1.0
|
CAE
|
B:9R9402
|
4.3
|
70.7
|
1.0
|
CZ
|
B:PHE72
|
4.5
|
65.3
|
1.0
|
CE2
|
A:TYR42
|
4.5
|
72.2
|
1.0
|
CZ
|
A:TYR45
|
4.6
|
79.1
|
1.0
|
CD2
|
B:LEU147
|
4.6
|
79.5
|
1.0
|
CA
|
A:TYR42
|
4.6
|
83.2
|
1.0
|
CB
|
A:TYR45
|
4.7
|
82.2
|
1.0
|
C
|
B:ALA150
|
4.8
|
97.3
|
1.0
|
CG
|
A:TYR42
|
4.8
|
77.3
|
1.0
|
CG
|
A:LEU46
|
4.8
|
73.6
|
1.0
|
CD2
|
A:LEU46
|
4.9
|
66.4
|
1.0
|
OAP
|
B:9R9402
|
4.9
|
82.9
|
1.0
|
CD1
|
A:LEU46
|
4.9
|
70.2
|
1.0
|
CA
|
B:ALA150
|
4.9
|
94.9
|
1.0
|
N
|
B:SER151
|
5.0
|
97.5
|
1.0
|
NAG
|
B:9R9402
|
5.0
|
67.3
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 6a4i
Go back to
Chlorine Binding Sites List in 6a4i
Chlorine binding site 3 out
of 4 in the Crystal Structure of Human Tdo Inhibitor Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Human Tdo Inhibitor Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl402
b:93.0
occ:1.00
|
CLA
|
C:9R9402
|
0.0
|
93.0
|
1.0
|
CAB
|
C:9R9402
|
1.7
|
77.9
|
1.0
|
CAC
|
C:9R9402
|
2.6
|
71.3
|
1.0
|
CAA
|
C:9R9402
|
2.7
|
73.6
|
1.0
|
CD2
|
D:TYR45
|
3.3
|
88.6
|
1.0
|
CE2
|
D:TYR45
|
3.6
|
87.4
|
1.0
|
CB
|
C:ALA150
|
3.9
|
98.7
|
1.0
|
CAD
|
C:9R9402
|
3.9
|
68.3
|
1.0
|
CE1
|
C:PHE72
|
4.0
|
72.2
|
1.0
|
CAF
|
C:9R9402
|
4.0
|
75.8
|
1.0
|
CG
|
D:TYR45
|
4.1
|
87.5
|
1.0
|
CD2
|
D:TYR42
|
4.2
|
94.6
|
1.0
|
CAE
|
C:9R9402
|
4.4
|
74.9
|
1.0
|
CG
|
C:LEU147
|
4.4
|
92.5
|
1.0
|
CB
|
D:TYR45
|
4.5
|
91.7
|
1.0
|
CZ
|
C:PHE72
|
4.6
|
74.7
|
1.0
|
CE2
|
D:TYR42
|
4.6
|
87.6
|
1.0
|
CZ
|
D:TYR45
|
4.6
|
85.7
|
1.0
|
CD1
|
C:LEU147
|
4.6
|
92.9
|
1.0
|
CA
|
D:TYR42
|
4.8
|
95.8
|
1.0
|
C
|
C:ALA150
|
5.0
|
0.5
|
1.0
|
O
|
D:TYR42
|
5.0
|
87.0
|
1.0
|
CD1
|
D:TYR45
|
5.0
|
88.7
|
1.0
|
CG
|
D:LEU46
|
5.0
|
86.0
|
1.0
|
CD1
|
C:PHE72
|
5.0
|
71.6
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6a4i
Go back to
Chlorine Binding Sites List in 6a4i
Chlorine binding site 4 out
of 4 in the Crystal Structure of Human Tdo Inhibitor Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of Human Tdo Inhibitor Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl402
b:82.9
occ:1.00
|
CLA
|
D:9R9402
|
0.0
|
82.9
|
1.0
|
CAB
|
D:9R9402
|
1.6
|
72.3
|
1.0
|
CAA
|
D:9R9402
|
2.6
|
69.7
|
1.0
|
CAC
|
D:9R9402
|
2.6
|
76.5
|
1.0
|
CD2
|
C:TYR45
|
3.3
|
95.1
|
1.0
|
CE2
|
C:TYR45
|
3.4
|
97.3
|
1.0
|
CB
|
D:ALA150
|
3.7
|
0.4
|
1.0
|
CE2
|
D:PHE72
|
3.7
|
95.6
|
1.0
|
CAD
|
D:9R9402
|
3.8
|
82.7
|
1.0
|
CAF
|
D:9R9402
|
3.9
|
74.2
|
1.0
|
CD2
|
C:TYR42
|
4.1
|
99.8
|
1.0
|
CG
|
C:TYR45
|
4.2
|
99.5
|
1.0
|
CAE
|
D:9R9402
|
4.4
|
79.3
|
1.0
|
CZ
|
C:TYR45
|
4.4
|
98.8
|
1.0
|
OAP
|
D:9R9402
|
4.4
|
91.1
|
1.0
|
CG
|
D:LEU147
|
4.4
|
0.1
|
1.0
|
CZ
|
D:PHE72
|
4.5
|
95.1
|
1.0
|
CD2
|
D:PHE72
|
4.7
|
92.2
|
1.0
|
CE2
|
C:TYR42
|
4.7
|
96.7
|
1.0
|
CA
|
C:TYR42
|
4.7
|
0.5
|
1.0
|
CB
|
C:TYR45
|
4.8
|
99.6
|
1.0
|
CD2
|
D:LEU147
|
4.8
|
0.1
|
1.0
|
CG
|
C:TYR42
|
4.8
|
0.1
|
1.0
|
CB
|
C:TYR42
|
4.9
|
0.5
|
1.0
|
CA
|
D:ALA150
|
5.0
|
0.1
|
1.0
|
CD1
|
C:TYR45
|
5.0
|
1.0
|
1.0
|
|
Reference:
G.Fu,
J.Wang,
G.Luo,
G.Wu,
K.Qian.
Crystal Structure of Human Tdo Inhibitor Complex To Be Published.
Page generated: Fri Jul 26 21:53:08 2024
|